Pharmacogenetics to Avoid Adverse Drug Reactions

• অন্যান্য লেখক: López-Fernández, Luis A. (সম্পাদক)
• বিন্যাস: বৈদ্যুতিক গ্রন্থের অধ্যায়
• ভাষা: ইংরেজি
• প্রকাশিত: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• বিষয়গুলি: Medicine; 5-fluorouracil; capecitabine; fluoropyrimidine; thymidylate synthase; thymidylate synthase enhancer region; upstream stimulatory factor 1; adverse drug reactions; pharmacogenomics; epistasis; random forest; statin; cardiovascular disease; colorectal cancer; personalised medicine; toxicity; (es)citalopram; drug-gene-interaction; drug-drug-interaction; drug-drug-gene-interaction; the PharmLines initiative; antipsychotic agents; pharmacogenetics; cytochrome P-450 enzyme system; psychotic disorders; precision medicine; direct oral anticoagulants; clinical implementation; atorvastatin; SLCO1B1; HLA; cutaneous adverse drug reaction; SCAR; genetic polymorphism; antiepileptics; CYP450 enzymes; platelet reactivity; single-nucleotide variants; acute coronary syndrome; clopidogrel; genotype; allele; polymorphism; HLA B; CYP2C9*3; cutaneous adverse drug reactions (CADRs); anti-epileptic drugs (AEDS); phenytoin (PHT); genetic risk factors; South India; India; cardiology; adverse events; guidelines; n/a
• অনলাইন ব্যবহার করুন: DOAB: download the publication; DOAB: description of the publication

Adverse drug reactions are one of the major constraints when using drugs. These adverse reactions can impact healthcare systems as strongly as many prevalent diseases. Identifying DNA variants associated with adverse drug reactions can help personalize medicine and sustain healthcare systems. This b...